The Clinical Characteristic and Management of Patients with Nocardiosis in a Tertiary Hospital in China
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Nocardiosis is an uncommon opportunistic bacterial infection which becomes a significant health problem due to its increasing incidence and high mortality rate. However, many nocardiosis patients are underdiagnosed by physicians. To summarize the clinical characteristics and management of nocardiosis would help with better diagnosis and prognosis of nocardiosis. This retrospective study was conducted based on the medical records of nocardiosis patients between January 2015 and December 2021 in a tertiary hospital in China. Overall, 44 nocardiosis patients with 54 specimens were included. The patients consisted of 26 males and 18 females with a mean age of 50.4 ± 13.2 years. Among 44 patients, 26 (59.1%) were previously given immunosuppressive therapy. Connective tissue diseases (CTDs) were the most common underlying disease (16/44). The most frequent infection sites were the lungs (17/44) and skin or soft tissues (8/44). Common symptoms included cough (23/44), expectoration (18/44), fever (15/44), and subcutaneous abscesses (15/44). Forty-five out of 54 specimens (83.3%) required over 48 hours of culture time for nocardiosis detection. Thirty-six patients were cured or improved, 5 patients were discharged from the hospital due to poor prognosis, and 1 patient died. The average diagnosis time of poor prognosis cases was 19.7 days, which was significantly longer than those of improved or cured patients (7.3 days). Immunosuppressed patients comprise a large part of nocardiosis cases, which is worth attention in clinical practice. Early diagnosis, specifically through prolonged cultivation time of specimen, could help achieve better prognosis of nocardiosis patients.
Abstract
Nocardiosis is an uncommon opportunistic bacterial infection which becomes a significant health problem due to its increasing incidence and high mortality rate. However, many nocardiosis patients are underdiagnosed by physicians. To summarize the clinical characteristics and management of nocardiosis would help with better diagnosis and prognosis of nocardiosis. This retrospective study was conducted based on the medical records of nocardiosis patients between January 2015 and December 2021 in a tertiary hospital in China. Overall, 44 nocardiosis patients with 54 specimens were included. The patients consisted of 26 males and 18 females with a mean age of 50.4 ± 13.2 years. Among 44 patients, 26 (59.1%) were previously given immunosuppressive therapy. Connective tissue diseases (CTDs) were the most common underlying disease (16/44). The most frequent infection sites were the lungs (17/44) and skin or soft tissues (8/44). Common symptoms included cough (23/44), expectoration (18/44), fever (15/44), and subcutaneous abscesses (15/44). Forty-five out of 54 specimens (83.3%) required over 48 hours of culture time for nocardiosis detection. Thirty-six patients were cured or improved, 5 patients were discharged from the hospital due to poor prognosis, and 1 patient died. The average diagnosis time of poor prognosis cases was 19.7 days, which was significantly longer than those of improved or cured patients (7.3 days). Immunosuppressed patients comprise a large part of nocardiosis cases, which is worth attention in clinical practice. Early diagnosis, specifically through prolonged cultivation time of specimen, could help achieve better prognosis of nocardiosis patients.
참고문헌 (37)
- Nakamura I, "Nocardia elegans infection: a case report and literature review", Int. J. Infect. Dis, 54, pp.15~17 (2017)
- Wilson JW, "Nocardiosis: updates and clinical overview", Mayo Clin. Proc, 87, pp.403~407 (2012)
- Martinez R, "Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis", Curr. Opin. Pulm. Med, 14, pp.219~227 (2008)
- Conville PS, "The complexities of nocardia taxonomy and identification", J. Clin. Microbiol, 56, pp.e01419-17~ (2018)
- Minero MV, "Nocardiosis at the turn of the century", Medicine (Baltimore), 88, pp.250~261 (2009)
- Carrasco G, "Identification, typing, and phylogenetic relationships of the main clinical Nocardia species in spain according to their gyrB and rpoB genes", J. Clin. Microbiol, 51, pp.3602~3608 (2013)
- Jiang Y, "Disseminated nocardiosis caused by Nocardia otitidiscaviarum in an immunocompetent host: a case report and literature review", Exp. Ther. Med, 12, pp.3339~3346 (2016)
- Corsini Campioli C, "Clinical presentation, management, and outcomes of patients with brain abscess due to Nocardia species", Open Forum Infect. Dis, 8, pp.ofab067~ (2021)
- Lynch JP, 3rd, "Nocardia spp.: a rare cause of pneumonia globally", Semin. Respir. Crit. Care Med, 41, pp.538~554 (2020)
- Mehta HH, "Pathogenic Nocardia: a diverse genus of emerging pathogens or just poorly recognized?", PLoS Pathog, 16, pp.e1008280~ (2020)
- Wintheiser GA, "Disseminated Nocardia in an immunocompetent host", Mayo Clin. Proc, 96, pp.847~848 (2021)
- Coussement J, "Nocardia infection in solid organ transplant recipients: A multicenter European case-control study", Clin. Infect. Dis, 63, pp.338~345 (2016)
- Weng SS, "Rapid detection of Nocardia by next-generation sequencing", Front. Cell. Infect. Microbiol, 10, pp.13~ (2020)
- Agterof MJ, "Nocardiosis: a case series and a mini review of clinical and microbiological features", Neth. J. Med, 65, pp.199~202 (2007)
- Wang H, "Epidemiology and antimicrobial resistance profiles of the Nocardia species in China, 2009 to 2021", Microbiol. Spectr, 10, pp.e0156021~ (2022)
- Brown-Elliott BA, "Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy", Clin. Microbiol. Rev, 19, pp.259~282 (2006)
- Paige EK, "Nocardiosis: 7-year experience at an Australian tertiary hospital", Intern. Med. J, 49, pp.373~379 (2019)
- Liu WL, "Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: a multicenter study from 1998 to 2010", Eur. J. Clin. Microbiol. Infect. Dis, 30, pp.1341~1347 (2011)
- Margalit I, "How do I manage nocardiosis?", Clin. Microbiol. Infect, 27, pp.550~558 (2021)
- Huang L, "Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017", Diagn. Microbiol. Infect. Dis, 94, pp.165~172 (2019)
- Mari B, "Pulmonary nocardiosis: clinical experience in ten cases", Respiration, 68, pp.382~388 (2001)
- Kudru CU, "A ten-year retrospective analysis of nocardiosis in a tertiary care center of South-coastal India", Infez. Med, 29, pp.600~608 (2021)
- Margalit I, "Clinical correlates of nocardiosis", Sci. Rep, 10, pp.14272~ (2020)
- Fatahi-Bafghi M, "Nocardiosis from 1888 to 2017", Microb. Pathog, 114, pp.369~384 (2018)
- Wang A, "Orbital and intracranial Nocardia farcinica infection caused by trauma to the orbit: a case report", BMC Infect. Dis, 19, pp.953~ (2019)
- Sawai T, "Detection of high serum levels of beta-D-Glucan in disseminated nocardial infection: a case report", BMC Infect. Dis, 17, pp.272~ (2017)
- Jiao M, "Case report: a severe and multi-Site Nocardia farcinica infection rapidly and precisely identified by metagenomic next-generation sequencing", Front. Med. (Lausanne), 8, pp.669552~ (2021)
- Saubolle MA, "Nocardiosis: review of clinical and laboratory experience", J. Clin. Microbiol, 41, pp.4497~4501 (2003)
- Toyokawa M, "Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in Japan", Sci. Rep, 11, pp.16742~ (2021)
- Uhde KB, "Antimicrobial-resistant nocardia isolates, United States, 1995-2004", Clin. Infect. Dis, 51, pp.1445~1448 (2010)
- Lebeaux D, "Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015", Clin. Microbiol. Infect, 25, pp.489~495 (2019)
- Sah R, "Disseminated infection with Nocardia otitidiscaviarum in a patient under steroid therapy", Clin. Case Rep, 8, pp.369~373 (2020)
- Yagishita M, "Clinical features and prognosis of nocardiosis in patients with connective tissue diseases", Mod. Rheumatol, 31, pp.636~642 (2021)
- Larruskain J, "Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents", Antimicrob. Agents Chemother, 55, pp.2995~2998 (2011)
- Gilbert DN, "The Sanford guide to antimicrobial therapy", pp.7~ (2018)
- Tremblay J, "Nocardiosis in Quebec, Canada, 1988-2008", Clin. Microbiol. Infect, 17, pp.690~696 (2011)
- Xu H, "Disseminated Nocardiosis with subretinal abscess in a patient with nephrotic syndrome-a case report", BMC Ophthalmol, 18, pp.234~ (2018)